Last Updated: May 12, 2026

Padagis Us Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Padagis Us
International Patents:22
US Patents:1
Tradenames:68
Ingredients:64
NDAs:92
PTAB Cases with Padagis Us as petitioner: See PTAB cases with Padagis Us as petitioner

Drugs and US Patents for Padagis Us

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Padagis Us TOBRAMYCIN AND DEXAMETHASONE dexamethasone; tobramycin SUSPENSION/DROPS;OPHTHALMIC 212715-001 Feb 11, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial
Padagis Us SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 078649-001 Mar 23, 2009 AB RX No No ⤷  Start Trial ⤷  Start Trial
Padagis Us HYDROCORTISONE hydrocortisone CREAM;TOPICAL 085025-001 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Start Trial ⤷  Start Trial
Padagis Us TROSPIUM CHLORIDE trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 201291-001 May 24, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Padagis Us

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Padagis Us EVAMIST estradiol SPRAY;TRANSDERMAL 022014-001 Jul 27, 2007 6,299,900 ⤷  Start Trial
Padagis Us BUTOCONAZOLE NITRATE butoconazole nitrate CREAM;VAGINAL 019881-001 Feb 7, 1997 5,266,329 ⤷  Start Trial
Padagis Us CENTANY mupirocin OINTMENT;TOPICAL 050788-001 Dec 4, 2002 6,013,657 ⤷  Start Trial
Padagis Us BUTOCONAZOLE NITRATE butoconazole nitrate CREAM;VAGINAL 019881-001 Feb 7, 1997 4,078,071 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for PADAGIS US drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Vaginal Cream 2% ➤ Subscribe 2015-02-05
➤ Subscribe Enteric Coated Capsules 3 mg ➤ Subscribe 2008-02-01

Supplementary Protection Certificates for Padagis Us Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1267866 122014000025 Germany ⤷  Start Trial PRODUCT NAME: GLYCOPYRRONIUM ODER EIN SALZ ODER DERIVAT HIERVON (KOMPONENTE 1) UND INDACATEROL ODER EIN DERIVAT HIERVON ODER EIN SALZ VON INDACATEROL ODER EINEM DERIVAT HIERVON (KOMPONENTE 2); REGISTRATION NO/DATE: EU/1/13/862 20130919
1304992 CR 2013 00053 Denmark ⤷  Start Trial PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
1441735 2008/010 Ireland ⤷  Start Trial PRODUCT NAME: RALTEGRAVIR OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; NAT AUTHORISTION NO/DATE: EU/1/07/436/001-002 20071220;
0303507 64/1997 Austria ⤷  Start Trial PRODUCT NAME: ''NARATRIPTAN'', GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER SOLVATES EINSCHLIESSLICH DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: 1-22059 19970731; FIRST REGISTRATION: SE 13382 19970310
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.